NM_001567.4(INPPL1):c.3549_3550insA (p.Glu1184fs) AND Opsismodysplasia

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: Jan 22, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001330612.1

Allele description [Variation Report for NM_001567.4(INPPL1):c.3549_3550insA (p.Glu1184fs)]

NM_001567.4(INPPL1):c.3549_3550insA (p.Glu1184fs)

Gene:

INPPL1:inositol polyphosphate phosphatase like 1 [Gene - OMIM - HGNC]

Variant type:

Insertion

Cytogenetic location:

11q13.4

Genomic location:

Preferred name:

NM_001567.4(INPPL1):c.3549_3550insA (p.Glu1184fs)

HGVS:

NC_000011.10:g.72237793_72237794insA
NG_008169.1:g.11383_11384insT
NG_023253.2:g.17956_17957insA
NM_001567.4:c.3549_3550insAMANE SELECT
NP_001558.3:p.Glu1184fs
NC_000011.9:g.71948837_71948838insA
NM_001567.3:c.3549_3550insA

Protein change:

E1184fs

Links:

dbSNP: rs1949036008

NCBI 1000 Genomes Browser:

rs1949036008

Molecular consequence:

NM_001567.4:c.3549_3550insA - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Opsismodysplasia (OPSMD)
Identifiers:: MONDO: MONDO:0009785; MedGen: C0432219; Orphanet: 2746; OMIM: 258480

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001522347	Baylor Genetics	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely pathogenic (Jan 22, 2020)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001522347

Baylor Genetics

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely pathogenic
(Jan 22, 2020)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Baylor Genetics, SCV001522347.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jun 3, 2023

ClinVar

Relating variation to medicine